Home Healthcare Pharmaceuticals Age Related Macular Degeneration Market

Age Related Macular Degeneration Market Size, Share & Trends Analysis Report By Product (Eylea, Lucentis, Beovu, Vabysmo, Avastin, Syfovre, Izervay, Biosimilars), By Disease Type (Wet AMD, Dry AMD), By Distribution Channel (Hospital pharmacies, Drug Stores & Retail Pharmacies, Specialty Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 01, 2026 | Author: Straits Research Team | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Age Related Macular Degeneration Market, By Product 2025-2034 (USD MILLION/ Units)
    1. Eylea
    2. Lucentis
    3. Beovu
    4. Vabysmo
    5. Avastin
    6. Syfovre
    7. Izervay
    8. Biosimilars
  2. Age Related Macular Degeneration Market, By Disease Type 2025-2034 (USD MILLION/ Units)
    1. Wet AMD
    2. Dry AMD
  3. Age Related Macular Degeneration Market, By Distribution Channel 2025-2034 (USD MILLION/ Units)
    1. Hospital pharmacies
    2. Drug Stores & Retail Pharmacies
    3. Specialty Pharmacies
  4. Regional Age Related Macular Degeneration Market
    1. North America
      1. North America Age Related Macular Degeneration Market By Product 2025-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
      2. North America Age Related Macular Degeneration Market By Disease Type 2025-2034 (USD MILLION/ Units)
        1. Wet AMD
        2. Dry AMD
      3. North America Age Related Macular Degeneration Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
      4. U.S.
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      5. Canada
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
    2. Europe
      1. Europe Age Related Macular Degeneration Market By Product 2025-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
      2. Europe Age Related Macular Degeneration Market By Disease Type 2025-2034 (USD MILLION/ Units)
        1. Wet AMD
        2. Dry AMD
      3. Europe Age Related Macular Degeneration Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
      4. U.K.
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      5. Germany
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      6. France
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      7. Spain
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      8. Italy
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      9. Russia
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      10. Nordic
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      11. Benelux
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      12. Rest of Europe
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
    3. APAC
      1. APAC Age Related Macular Degeneration Market By Product 2025-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
      2. APAC Age Related Macular Degeneration Market By Disease Type 2025-2034 (USD MILLION/ Units)
        1. Wet AMD
        2. Dry AMD
      3. APAC Age Related Macular Degeneration Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
      4. China
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      5. Korea
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      6. Japan
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      7. India
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      8. Australia
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      9. Taiwan
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      10. South East Asia
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      11. Rest of Asia-Pacific
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Age Related Macular Degeneration Market By Product 2025-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
      2. Middle East and Africa Age Related Macular Degeneration Market By Disease Type 2025-2034 (USD MILLION/ Units)
        1. Wet AMD
        2. Dry AMD
      3. Middle East and Africa Age Related Macular Degeneration Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
      4. UAE
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      5. Turkey
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      6. Saudi Arabia
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      7. South Africa
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      8. Egypt
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      9. Nigeria
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      10. Rest of MEA
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
    5. LATAM
      1. LATAM Age Related Macular Degeneration Market By Product 2025-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
      2. LATAM Age Related Macular Degeneration Market By Disease Type 2025-2034 (USD MILLION/ Units)
        1. Wet AMD
        2. Dry AMD
      3. LATAM Age Related Macular Degeneration Market By Distribution Channel 2025-2034 (USD MILLION/ Units)
        1. Hospital pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Specialty Pharmacies
      4. Brazil
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      5. Mexico
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      6. Argentina
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      7. Chile
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      8. Colombia
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
      9. Rest of LATAM
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Avastin
        6. Syfovre
        7. Izervay
        8. Biosimilars
        9. Wet AMD
        10. Dry AMD
        11. Hospital pharmacies
        12. Drug Stores & Retail Pharmacies
        13. Specialty Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.